更多...
This gene encodes a serine protease involved in degradation of the extracellular matrix and possibly tumor cell migration and proliferation. A specific polymorphism in this gene may be associated with late-onset Alzheimer's disease and also with decreased affinity for fibrin-binding. This protein converts plasminogen to plasmin by specific cleavage of an Arg-Val bond in plasminogen. Plasmin in turn cleaves this protein at a Lys-Ile bond to form a two-chain derivative in which a single disulfide bond connects the amino-terminal A-chain to the catalytically active, carboxy-terminal B-chain. This two-chain derivative is also called HMW-uPA (high molecular weight uPA). HMW-uPA can be further processed into LMW-uPA (low molecular weight uPA) by cleavage of chain A into a short chain A (A1) and an amino-terminal fragment. LMW-uPA is proteolytically active but does not bind to the uPA receptor. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009]
[中文简述(自动翻译):] 该基因编码参与细胞外基质的降解,并可能肿瘤细胞迁移和增殖的丝氨酸蛋白酶。在该基因的具体多态性可能与迟发型阿尔茨海默氏病相关联,并且还具有降低的亲和力的纤维蛋白结合。这种蛋白由纤维蛋白溶酶原的精氨酸 - 瓦尔债券的具体裂解转化纤溶酶原为纤溶酶。纤溶酶反过来切割该蛋白在一个赖氨酸 - 异亮氨酸键,以形成在其中单个二硫键的氨基末端A链连接到催化活性,羧基端B链的两链衍生物。该双链衍生物也称为HMW-uPA的(高分子量的uPA)。 HMW-uPA的可以由链A的切割进一步加工成LMW-uPA的(低分子量的uPA)成短链中的(A1)和氨基末端片段。 LMW-uPA的是蛋白水解活性的,但不绑定到特异受体。已发现该基因编码不同亚型选择性剪接转录变异体。 [由RefSeq的,2009年2月提供]
PLAU基因(以及对应的蛋白质)的细胞分布位置:
PLAU基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Alzheimer's Disease | 0.225099593 | 6 | 0 | CTD_human_GAD_LHGDN_MGD |
Myocardial Infarction | 0.202638474 | 8 | 0 | BeFree_CTD_human_GAD_RGD |
Reperfusion Injury | 0.2 | 2 | 0 | CTD_human_RGD |
Thrombosis | 0.2 | 7 | 0 | CTD_human_RGD |
Intracranial Hemorrhages | 0.2 | 5 | 0 | CTD_human_RGD |
Asthenozoospermia | 0.2 | 1 | 0 | CTD_human_RGD |
Brain Edema | 0.2 | 2 | 0 | CTD_human_RGD |
Neoplasm Metastasis | 0.150964236 | 97 | 0 | BeFree_CTD_human_LHGDN |
Prostatic Neoplasms | 0.136346101 | 8 | 0 | CTD_human_LHGDN |
Asthma | 0.128715934 | 5 | 0 | BeFree_CTD_human_LHGDN |
Adenocarcinoma | 0.127620235 | 10 | 0 | BeFree_CTD_human_LHGDN |
Pancreatic Neoplasm | 0.126263026 | 5 | 0 | BeFree_CTD_human_LHGDN |
Quebec platelet disorder | 0.123452799 | 4 | 0 | BeFree_GAD_ORPHANET |
Carcinoma, Transitional Cell | 0.122995792 | 2 | 0 | BeFree_CTD_human_LHGDN |
Idiopathic Pulmonary Fibrosis | 0.122995792 | 1 | 0 | BeFree_CTD_human_LHGDN |
Stomach Neoplasms | 0.12272435 | 2 | 0 | CTD_human_LHGDN |
Bone neoplasms | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Coronary heart disease | 0.120271442 | 3 | 1 | BeFree_CTD_human |
Liver Cirrhosis | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Angina Pectoris | 0.12 | 1 | 0 | CTD_human |
Angina, Unstable | 0.12 | 1 | 0 | CTD_human |
Anuria | 0.12 | 1 | 0 | CTD_human |
Arterial Occlusive Diseases | 0.12 | 4 | 0 | CTD_human |
Carotid Artery Diseases | 0.12 | 1 | 0 | CTD_human |
Intracranial Embolism and Thrombosis | 0.12 | 1 | 0 | CTD_human |
Cerebral Infarction | 0.12 | 3 | 0 | CTD_human |
Brain Ischemia | 0.12 | 4 | 0 | CTD_human |
Cerebrovascular Disorders | 0.12 | 2 | 0 | CTD_human |
IGA Glomerulonephritis | 0.12 | 1 | 0 | CTD_human |
Graft Occlusion, Vascular | 0.12 | 4 | 0 | CTD_human |
Heart Rupture, Post-Infarction | 0.12 | 1 | 0 | CTD_human |
Hematuria | 0.12 | 1 | 0 | CTD_human |
Hemorrhage | 0.12 | 4 | 0 | CTD_human |
Hypotension | 0.12 | 1 | 0 | CTD_human |
Inflammatory Bowel Diseases | 0.12 | 1 | 1 | GWASCAT |
Ischemia | 0.12 | 2 | 0 | CTD_human |
Neoplasm Invasiveness | 0.12 | 2 | 0 | CTD_human |
Neoplasm Recurrence, Local | 0.12 | 1 | 0 | CTD_human |
Nephritis | 0.12 | 1 | 0 | CTD_human |
Pulmonary Embolism | 0.12 | 6 | 0 | CTD_human |
Henoch-Schoenlein Purpura | 0.12 | 2 | 0 | CTD_human |
Cerebrovascular accident | 0.12 | 1 | 0 | CTD_human |
Thromboembolism | 0.12 | 1 | 0 | CTD_human |
Venous Thrombosis | 0.12 | 4 | 0 | CTD_human |
Ventricular Fibrillation | 0.12 | 1 | 0 | CTD_human |
Cholesterol Embolism | 0.12 | 1 | 0 | CTD_human |
Sagittal Sinus Thrombosis | 0.12 | 1 | 0 | CTD_human |
Infarction, Middle Cerebral Artery | 0.12 | 3 | 0 | CTD_human |
Cerebral Hemorrhage | 0.12 | 5 | 0 | CTD_human |
Mammary Neoplasms | 0.106147803 | 16 | 0 | BeFree_LHGDN_RGD |
Bladder Neoplasm | 0.088173051 | 4 | 0 | LHGDN_RGD |
Chronic Obstructive Airway Disease | 0.082995792 | 3 | 0 | BeFree_LHGDN_RGD |
Acute Lung Injury | 0.08272435 | 3 | 0 | LHGDN_RGD |
Pulmonary Fibrosis | 0.081085767 | 5 | 0 | BeFree_RGD |
Kidney Failure, Chronic | 0.080271442 | 2 | 0 | BeFree_RGD |
Liver Cirrhosis, Experimental | 0.080271442 | 3 | 0 | BeFree_RGD |
Transient Ischemic Attack | 0.08 | 2 | 0 | RGD |
Diabetic Nephropathy | 0.08 | 1 | 0 | RGD |
Cardiomegaly | 0.08 | 1 | 0 | RGD |
Liver Cirrhosis, Alcoholic | 0.08 | 1 | 0 | RGD |
Mammary Neoplasms, Experimental | 0.08 | 1 | 0 | RGD |
Status Epilepticus | 0.08 | 2 | 0 | RGD |
Sciatic Neuropathy | 0.08 | 2 | 0 | RGD |
Strongylida Infections | 0.08 | 1 | 0 | RGD |
Hyperoxia | 0.08 | 1 | 0 | RGD |
Lung Injury | 0.08 | 1 | 0 | RGD |
Hypoxia-Ischemia, Brain | 0.08 | 2 | 0 | RGD |
Breast Carcinoma | 0.013572094 | 50 | 0 | BeFree |
Malignant neoplasm of breast | 0.013300652 | 49 | 0 | BeFree |
Colorectal Neoplasms | 0.011440285 | 6 | 0 | BeFree_LHGDN |
Glioblastoma | 0.010334654 | 20 | 0 | BeFree_LHGDN |
Colorectal Cancer | 0.009815515 | 10 | 0 | BeFree_GAD |
Liver carcinoma | 0.009520329 | 16 | 0 | BeFree_LHGDN |
Malignant neoplasm of prostate | 0.009424521 | 27 | 0 | BeFree_GAD |
Squamous cell carcinoma | 0.008977445 | 15 | 0 | BeFree_LHGDN |
Malignant neoplasm of ovary | 0.008805692 | 17 | 0 | BeFree_GAD |
Endometriosis | 0.008715934 | 4 | 0 | BeFree_LHGDN |
ovarian neoplasm | 0.008715934 | 5 | 0 | BeFree_LHGDN |
Glioma | 0.00842463 | 22 | 0 | BeFree_LHGDN |
Inflammation | 0.008173051 | 3 | 0 | LHGDN |
Prostate carcinoma | 0.006786047 | 25 | 0 | BeFree |
Malignant neoplasm of lung | 0.006362715 | 8 | 0 | BeFree_GAD |
Meningioma | 0.006263026 | 5 | 0 | BeFree_LHGDN |
Thyroid Neoplasm | 0.005720142 | 3 | 0 | BeFree_LHGDN |
Rheumatoid Arthritis | 0.005634266 | 3 | 0 | BeFree_GAD_LHGDN |
Colonic Neoplasms | 0.0054487 | 2 | 0 | LHGDN |
Hyperplasia | 0.0054487 | 2 | 0 | LHGDN |
Mitral Valve Prolapse Syndrome | 0.005362824 | 1 | 0 | BeFree_GAD_LHGDN |
Tumor Progression | 0.005157396 | 19 | 0 | BeFree |
melanoma | 0.004353001 | 7 | 0 | BeFree_LHGDN |
Stomach Carcinoma | 0.00434307 | 16 | 0 | BeFree |
Malignant neoplasm of stomach | 0.004071628 | 15 | 0 | BeFree |
Ovarian Carcinoma | 0.004071628 | 15 | 0 | BeFree |
Renal Cell Carcinoma | 0.003810118 | 4 | 0 | BeFree_LHGDN |
Atherosclerosis | 0.003538676 | 4 | 0 | BeFree_LHGDN |
Sarcoma | 0.003538676 | 3 | 0 | BeFree_LHGDN |
Colon Carcinoma | 0.003257302 | 12 | 0 | BeFree |
Cardiovascular Diseases | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Pneumonia | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Malignant tumor of colon | 0.002985861 | 11 | 0 | BeFree |
Colorectal Carcinoma | 0.002985861 | 11 | 0 | BeFree |
Malignant neoplasm of mouth | 0.002909916 | 3 | 0 | BeFree_GAD |
Chordoma | 0.00272435 | 1 | 0 | LHGDN |
Cystic Fibrosis | 0.00272435 | 1 | 0 | LHGDN |
Dermatitis | 0.00272435 | 1 | 0 | LHGDN |
Dermatitis, Atopic | 0.00272435 | 1 | 0 | LHGDN |
Esophageal Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
Hemoglobinuria, Paroxysmal | 0.00272435 | 1 | 0 | LHGDN |
Lung Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
Mouth Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
Degenerative polyarthritis | 0.00272435 | 1 | 0 | LHGDN |
Periodontal Diseases | 0.00272435 | 1 | 0 | LHGDN |
Prostatic Intraepithelial Neoplasias | 0.00272435 | 1 | 0 | LHGDN |
Osteoarthritis, Knee | 0.00272435 | 1 | 0 | LHGDN |
Infection | 0.00272435 | 1 | 0 | LHGDN |
Diabetes Mellitus, Insulin-Dependent | 0.002638474 | 1 | 0 | BeFree_GAD |
Chorioamnionitis | 0.002367032 | 1 | 0 | GAD |
Fetal Membranes, Premature Rupture | 0.002367032 | 1 | 0 | GAD |
Premature Obstetric Labor | 0.002367032 | 1 | 0 | GAD |
Multiple Sclerosis | 0.002367032 | 1 | 0 | GAD |
Osteoporosis | 0.002367032 | 1 | 0 | GAD |
Pneumoconiosis | 0.002367032 | 1 | 0 | GAD |
Polycystic Ovary Syndrome | 0.002367032 | 1 | 0 | GAD |
Pre-Eclampsia | 0.002367032 | 1 | 0 | GAD |
Respiratory Distress Syndrome, Adult | 0.002367032 | 1 | 0 | GAD |
Premature Birth | 0.002367032 | 1 | 0 | GAD |
Nephrolithiasis | 0.002367032 | 1 | 0 | GAD |
Urolithiasis | 0.002367032 | 1 | 0 | GAD |
Hepatopulmonary Syndrome | 0.002367032 | 1 | 0 | GAD |
Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | 0.002367032 | 1 | 0 | GAD |
Severe Combined Immunodeficiency | 0.002171535 | 8 | 0 | BeFree |
Secondary malignant neoplasm of lymph node | 0.002171535 | 8 | 0 | BeFree |
Immunologic Deficiency Syndromes | 0.001628651 | 6 | 0 | BeFree |
Pancreatic carcinoma | 0.001628651 | 6 | 0 | BeFree |
Malignant neoplasm of pancreas | 0.001628651 | 6 | 0 | BeFree |
Carcinoma of lung | 0.001628651 | 6 | 0 | BeFree |
Non-Small Cell Lung Carcinoma | 0.001357209 | 5 | 0 | BeFree |
Blood Coagulation Disorders | 0.001085767 | 4 | 0 | BeFree |
Brain Neoplasms | 0.001085767 | 4 | 0 | BeFree |
Hepatitis B | 0.001085767 | 4 | 0 | BeFree |
Anaplastic astrocytoma | 0.001085767 | 4 | 0 | BeFree |
Arteriosclerosis | 0.000814326 | 3 | 0 | BeFree |
Noninfiltrating Intraductal Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Fibrosarcoma | 0.000814326 | 3 | 0 | BeFree |
Secondary malignant neoplasm of lung | 0.000814326 | 3 | 0 | BeFree |
Carcinoma breast stage IV | 0.000814326 | 3 | 0 | BeFree |
Solid tumour | 0.000814326 | 3 | 0 | BeFree |
Endometrial Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Secondary malignant neoplasm of liver | 0.000814326 | 3 | 0 | BeFree |
Carcinogenesis | 0.000814326 | 3 | 0 | BeFree |
Invasive breast carcinoma | 0.000814326 | 3 | 0 | BeFree |
Tumor Angiogenesis | 0.000814326 | 3 | 0 | BeFree |
Adenoma | 0.000542884 | 2 | 0 | BeFree |
Aortic Aneurysm | 0.000542884 | 2 | 0 | BeFree |
Astrocytoma | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of urinary bladder | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of endometrium | 0.000542884 | 2 | 0 | BeFree |
Chondrosarcoma | 0.000542884 | 2 | 0 | BeFree |
Hepatitis C | 0.000542884 | 2 | 0 | BeFree |
HIV Infections | 0.000542884 | 2 | 0 | BeFree |
Medulloblastoma | 0.000542884 | 2 | 0 | BeFree |
Muscular Dystrophy | 0.000542884 | 2 | 0 | BeFree |
Osteosarcoma | 0.000542884 | 2 | 0 | BeFree |
Pterygium | 0.000542884 | 2 | 0 | BeFree |
Kidney Failure | 0.000542884 | 2 | 0 | BeFree |
Systemic Scleroderma | 0.000542884 | 2 | 0 | BeFree |
Liver Failure | 0.000542884 | 2 | 0 | BeFree |
Liver and Intrahepatic Biliary Tract Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Adenocarcinoma of pancreas | 0.000542884 | 2 | 0 | BeFree |
Cervix carcinoma | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of liver | 0.000542884 | 2 | 0 | BeFree |
Disseminated Malignant Neoplasm | 0.000542884 | 2 | 0 | BeFree |
Secondary malignant neoplasm of pancreas | 0.000542884 | 2 | 0 | BeFree |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.000542884 | 2 | 0 | BeFree |
Alzheimer Disease, Late Onset | 0.000542884 | 2 | 0 | BeFree |
Osteosarcoma of bone | 0.000542884 | 2 | 0 | BeFree |
Carcinoma of bladder | 0.000542884 | 2 | 0 | BeFree |
Malignant Pleural Mesothelioma | 0.000542884 | 2 | 0 | BeFree |
Invasive Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Pancreatic Ductal Adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Breast Cancer Model | 0.000542884 | 2 | 0 | BeFree |
Meningioma, benign, no ICD-O subtype | 0.000542884 | 2 | 0 | BeFree |
Uterine Corpus Cancer | 0.000542884 | 2 | 0 | BeFree |
Aneurysm | 0.000271442 | 1 | 0 | BeFree |
Biliary Atresia | 0.000271442 | 1 | 0 | BeFree |
Coronary Arteriosclerosis | 0.000271442 | 1 | 1 | BeFree |
Adenoid Cystic Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Cystadenoma, Mucinous | 0.000271442 | 1 | 0 | BeFree |
Dermatitis Herpetiformis | 0.000271442 | 1 | 0 | BeFree |
Scleroderma | 0.000271442 | 1 | 0 | BeFree |
Von Hippel-Lindau Syndrome | 0.000271442 | 1 | 0 | BeFree |
Keratoconjunctivitis, Vernal | 0.000271442 | 1 | 0 | BeFree |
Leg Ulcer | 0.000271442 | 1 | 0 | BeFree |
Leukemia, Lymphocytic, Acute, L1 | 0.000271442 | 1 | 0 | BeFree |
Leukemia, Myelocytic, Acute | 0.000271442 | 1 | 0 | BeFree |
Myeloid Leukemia | 0.000271442 | 1 | 0 | BeFree |
Acute myelomonocytic leukemia | 0.000271442 | 1 | 0 | BeFree |
Liver neoplasms | 0.000271442 | 1 | 0 | BeFree |
Lymphatic Metastasis | 0.000271442 | 1 | 0 | BeFree |
Meleda Disease | 0.000271442 | 1 | 0 | BeFree |
Bullous pemphigoid | 0.000271442 | 1 | 0 | BeFree |
Precancerous Conditions | 0.000271442 | 1 | 0 | BeFree |
Proctitis | 0.000271442 | 1 | 0 | BeFree |
Respiratory Tract Infections | 0.000271442 | 1 | 0 | BeFree |
Rhabdomyosarcoma | 0.000271442 | 1 | 0 | BeFree |
Seminoma | 0.000271442 | 1 | 0 | BeFree |
Gastric ulcer | 0.000271442 | 1 | 0 | BeFree |
Synovitis | 0.000271442 | 1 | 0 | BeFree |
Pleural Effusion, Malignant | 0.000271442 | 1 | 0 | BeFree |
Bone pain | 0.000271442 | 1 | 0 | BeFree |
Arterial thrombosis | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of brain | 0.000271442 | 1 | 0 | BeFree |
Acute myocardial infarction | 0.000271442 | 1 | 0 | BeFree |
Cicatrix, Hypertrophic | 0.000271442 | 1 | 0 | BeFree |
Embryonal Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Carcinoma, Neuroendocrine | 0.000271442 | 1 | 0 | BeFree |
Cholangiocarcinoma | 0.000271442 | 1 | 0 | BeFree |
gliosarcoma | 0.000271442 | 1 | 0 | BeFree |
Effects of heat | 0.000271442 | 1 | 0 | BeFree |
Paroxysmal atrial fibrillation | 0.000271442 | 1 | 0 | BeFree |
Anaplastic thyroid carcinoma | 0.000271442 | 1 | 0 | BeFree |
Fibrosis, Liver | 0.000271442 | 1 | 0 | BeFree |
Malignant Meningioma | 0.000271442 | 1 | 0 | BeFree |
Carcinoma of ampulla of Vater | 0.000271442 | 1 | 0 | BeFree |
Renal glomerular disease | 0.000271442 | 1 | 0 | BeFree |
Stage IV Ovarian Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Metastatic melanoma | 0.000271442 | 1 | 0 | BeFree |
Cancer of Head and Neck | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of esophagus | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma of colon | 0.000271442 | 1 | 0 | BeFree |
Pulmonary lymphangioleiomyomatosis | 0.000271442 | 1 | 0 | BeFree |
Erythrokeratoderma | 0.000271442 | 1 | 0 | BeFree |
Malignant Glioma | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of mouth | 0.000271442 | 1 | 0 | BeFree |
Epithelial ovarian cancer | 0.000271442 | 1 | 0 | BeFree |
Primary malignant neoplasm of brain | 0.000271442 | 1 | 0 | BeFree |
Thrombocytosis | 0.000271442 | 1 | 0 | BeFree |
Advanced cancer | 0.000271442 | 1 | 0 | BeFree |
Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
Stromal Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Ischemic stroke | 0.000271442 | 1 | 0 | BeFree |
Invasive Ductal Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Rhinorrhea | 0.000271442 | 1 | 0 | BeFree |
Precursor B-cell lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
Adenoma of large intestine | 0.000271442 | 1 | 0 | BeFree |
Pleural Mesothelioma | 0.000271442 | 1 | 0 | BeFree |
Renal carcinoma | 0.000271442 | 1 | 0 | BeFree |
Cardiac fibrosis | 0.000271442 | 1 | 0 | BeFree |
Hepatocarcinogenesis | 0.000271442 | 1 | 0 | BeFree |
Glioblastoma Multiforme | 0.000271442 | 1 | 0 | BeFree |
tumor vasculature | 0.000271442 | 1 | 0 | BeFree |
Laryngeal cleft | 0.000271442 | 1 | 0 | BeFree |
Coronary Artery Disease | 0.000271442 | 1 | 1 | BeFree |
Limb ischemia | 0.000271442 | 1 | 0 | BeFree |
Intracranial glioma | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。